CALSADA CRISPINA (Chief Financial Officer) sold 49.1% of their position (43.80K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market sale worth $55.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/15/2025ACC: 0000950170-25-005881
Officer· Chief Financial Officer
Since Aug 2019
-43.80K
Net shares
Net seller
$55.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
43.80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−38.72K
Price / share
$1.26
Trade value
$48.91K
% of position
43.4%
1/13/2025
89.28K→50.57K
Common Stock
Direct
Shares
−5.09K
Price / share
$1.26
Trade value
$6.43K
% of position
10.1%
1/14/2025
50.57K→45.48K
Total
Net shares
−43.80K
Net value
-$55.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | S · Sale | −38.72K | $1.26 | $48.91K | 43.4% | 89.28K | 50.57K |
| Common Stock Direct | 1/14/2025 | S · Sale | −5.09K | $1.26 | $6.43K | 10.1% | 50.57K | 45.48K |
| Total | −43.80K | -$55.33K | ||||||
Derivative Transactions0
No derivative transactions reported